Stock MOJO MOJAVE BRANDS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Mojave Brands Inc. Share Price

Equities

MOJO

CA6083842022

Pharmaceuticals

Market Closed - Canadian Securities Exchange
Other stock markets
 20:08:25 19/04/2024 BST 		5-day change 1st Jan Change
0.325 CAD +1.56% Intraday chart for Mojave Brands Inc. +1.56% -35.00%
04-19 Mojave Brands Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 CI
02-05 Mojave Brands Inc. announced that it expects to receive CAD 7.5 million in funding CI

Financials

Sales 2022 - Sales 2023 - Capitalization 563K 410K 32.75M
Net income 2022 - 0 0 Net income 2023 - 0 0 EV / Sales 2022 -
Net cash position 2022 841K 612K 48.9M Net cash position 2023 690K 502K 40.13M EV / Sales 2023 -
P/E ratio 2022
22.9 x
P/E ratio 2023
-8.18 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 79.53%
More Fundamentals * Assessed data

Chart Mojave Brands Inc.

Dynamic Chart

Latest news about Mojave Brands Inc.

Mojave Brands Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 CI
Mojave Brands Inc. announced that it expects to receive CAD 7.5 million in funding CI
Light AI Inc. entered into a binding letter of intent to acquire Mojave Brands Inc. (CNSX : MOJO) for CAD 15.89 million in a reverse merger transaction. CI
Light AI Inc. announced that it expects to receive CAD 7.5 million in funding from Mojave Brands Inc. CI
Mojave Brands Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023 CI
Mojave Brands Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 CI
Mojave Brands Inc. announced that it has received CAD 0.475986 million in funding CI
Mojave Brands Inc. announced that it expects to receive CAD 0.8855 million in funding CI
Mojave Brands Inc. Announces Chief Financial Officer Changes CI
Mojave Brands Inc. Announces Chief Executive Officer Changes CI
Mojave Brands Inc. Announces Board Changes CI
Mojave Brands Inc. Announces Board Changes CI
Mojave Brands Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023 CI
Mojave Brands Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023 CI
Mojave Brands Inc. Announces Resignation of Satnam Brar from the Board of Directors CI
More news

Press releases Mojave Brands Inc.

Mojave Brands Inc :. Announces Closing of Non-Brokered Private Placement AQ
Mojave Jane Sells Nelson & Mark as Board Proceeds towards Completion of Strategic Review NE
Mojave Jane Brands Announces Board Changes NE
CSE Bulletin: Reinstatement - Mojave Jane Brands Inc. (JANE) NE
Mojave Jane Brands : IIROC Trade Resumption - JANE AQ
More press releases

Quotes and Performance

1 day+1.56%
1 week+1.56%
3 months-31.58%
6 months+261.11%
Current year-35.00%
More quotes

Highs and lows

1 month
0.32
Extreme 0.32
0.33
Current year
0.27
Extreme 0.27
0.52
1 year
0.09
Extreme 0.09
0.52
3 years
0.09
Extreme 0.09
3.32
5 years
0.09
Extreme 0.09
38.00
10 years
0.09
Extreme 0.09
148.00
More quotes

Managers and Directors - Mojave Brands Inc.

Managers TitleAgeSince
Robert Dubeau CEO
 Chief Executive Officer - 25/09/23
Christopher Cooper DFI
 Director of Finance/CFO 54 18/09/23
Members of the board TitleAgeSince
Christopher Cooper DFI
 Director of Finance/CFO 54 18/09/23
Robert Dubeau CEO
 Chief Executive Officer - 25/09/23
Anderson Shannon BRD
 Director/Board Member - 18/09/23
More insiders

Quotes

Date Price Change Volume
29/04/24 - +-NaN% 45
26/04/24 - +-NaN% 50
24/04/24 - +-NaN% 54

Delayed Quote Canadian Securities Exchange, April 19, 2024 at 08:08 pm

More quotes

Company Profile

Mojave Brands Inc. is a Canada-based company. The Company's principal business was the manufacturing, processing and sale of cannabis extracts. The Company is not generating revenues as it has closed down all its operations in the United States, and plans to seek out other potential strategic alliances, joint venture, acquisitions, or merger opportunities.
Sector
Pharmaceuticals
Calendar
30/07/2024 - Q3 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

1st Jan change Capi.
MOJAVE BRANDS INC. Stock Mojave Brands Inc.
-35.00% 2.18M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.25% 704B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+28.59% 577B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.55% 348B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.16% 327B
ABBVIE INC. Stock AbbVie Inc.
+4.36% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.81% 234B
NOVARTIS AG Stock Novartis AG
+4.93% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-9.78% 194B
AMGEN INC. Stock Amgen Inc.
-3.69% 147B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. MOJO Stock